Continuous microdose (0.3 mg) quingestanol acetate as an oral contraceptive agent.
D000284:Administration, Oral; D000328:Adult; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D009649:Norpregnadienes / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects; D010298:Parity; D011247:Pregnancy; D012959:Socioeconomic Factors
D009649:Norpregnadienes